Tevis Investment Management’s AbbVie ABBV Stock Holding History

Tevis Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$870K	Hold	4,000	–	–	0.5%	51
2025 Q4	$926K	Hold	4,000	–	–	0.56%	58
2025 Q3	$926K	Hold	4,000	–	–	0.56%	58
2025 Q2	$742K	Hold	4,000	–	–	0.48%	61
2025 Q1	$711K	Hold	4,000	–	–	0.53%	56
2024 Q4	$711K	Hold	4,000	–	–	0.53%	56
2024 Q3	$790K	Hold	4,000	–	–	0.58%	54
2024 Q2	$686K	Hold	4,000	–	–	0.55%	54
2024 Q1	$728K	Hold	4,000	–	–	0.62%	51
2023 Q4	$620K	Hold	4,000	–	–	0.57%	53
2023 Q3	$596K	Hold	4,000	–	–	0.6%	55
2023 Q2	$539K	Hold	4,000	–	–	0.53%	59
2023 Q1	$637K	Hold	4,000	–	–	0.65%	50
2022 Q4	$646K	Hold	4,000	–	–	0.69%	49
2022 Q3	$537K	Hold	4,000	–	–	0.52%	55
2022 Q2	$613K	Hold	4,000	–	–	0.59%	54
2022 Q1	$648K	Hold	4,000	–	–	0.59%	52
2021 Q4	$542K	Buy	+4,000	New	+$473K	0.47%	64

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tevis Investment Management's ABBV Position: Q1 2026 in Review

Tevis Investment Management held its AbbVie (ABBV) position steady in Q1 2026 at 4,000 shares worth $870K. The position accounts for 0.5% of the portfolio, ranked #51.

Tevis Investment Management first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $926K in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Tevis Investment Management held 4,000 shares of AbbVie worth $870K as of Q1 2026.
Tevis Investment Management left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.5% of Tevis Investment Management's portfolio in Q1 2026, its #51 holding.
Tevis Investment Management first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
Tevis Investment Management's AbbVie position peaked at $926K in Q4 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Tevis Investment Management's 13F filing for Q1 2026, filed 4 May 2026.